Free Trial
NASDAQ:PBM

Psyence Biomedical (PBM) Stock Price, News & Analysis

Psyence Biomedical logo
$3.26 -0.09 (-2.69%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Psyence Biomedical Stock (NASDAQ:PBM)

Key Stats

Today's Range
$3.08
$3.37
50-Day Range
$2.36
$11.50
52-Week Range
$2.36
$334.80
Volume
95,340 shs
Average Volume
707,941 shs
Market Capitalization
$1.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Psyence Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

PBM MarketRank™: 

Psyence Biomedical scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Psyence Biomedical.

  • Price to Book Value per Share Ratio

    Psyence Biomedical has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.86% of the float of Psyence Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Psyence Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Psyence Biomedical has recently decreased by 52.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Psyence Biomedical does not currently pay a dividend.

  • Dividend Growth

    Psyence Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.86% of the float of Psyence Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Psyence Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Psyence Biomedical has recently decreased by 52.71%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Psyence Biomedical has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Psyence Biomedical this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for PBM on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Psyence Biomedical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Psyence Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.60% of the stock of Psyence Biomedical is held by insiders.

  • Percentage Held by Institutions

    77.44% of the stock of Psyence Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Psyence Biomedical's insider trading history.
Receive PBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter.

PBM Stock News Headlines

Washington Thinks They Own Your Bank Account
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

PBM Stock Analysis - Frequently Asked Questions

Psyence Biomedical's stock was trading at $16.8167 at the beginning of the year. Since then, PBM stock has decreased by 80.6% and is now trading at $3.26.

Psyence Biomedical Ltd. (NASDAQ:PBM) announced its earnings results on Thursday, January, 23rd. The company reported $4.06 EPS for the quarter.

Shares of Psyence Biomedical reverse split on Monday, May 5th 2025.A 100-797 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, May 4th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Psyence Biomedical's top institutional shareholders include Parallel Advisors LLC (48.25%).

Shares of PBM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/23/2025
Today
8/15/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PBM
Previous Symbol
NASDAQ:PBM
CIK
1985062
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.04
Quick Ratio
11.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$1.83 per share
Price / Cash Flow
1.80
Book Value
$11.83 per share
Price / Book
0.28

Miscellaneous

Outstanding Shares
570,000
Free Float
548,000
Market Cap
$1.88 million
Optionable
N/A
Beta
0.22
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PBM) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners